Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for
Aortic Stenosis
Location: Philadelphia PA, Summit NJ, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT05646381
Phase 2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Philadelphia PA, New York NY, Boston MA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Philadelphia PA, Staten Island NY, The Bronx NY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase 3, Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
for
Candidemia, Candidiasis, Invasive
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT05421858
Phase 3, Recruiting
PopSci CHW4CervixHealth
for
Cervical Cancer, Hpv, Human Papilloma Virus, HPV Infection
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 25 - 65
Code: NCT07336134
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: Philadelphia PA, New Brunswick NJ, Lancaster PA,
Sponsor: Criterium, Inc.
Sex: All
Age: 18+
Code: NCT06992258
Phase 2, Recruiting
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620